Port-au-Prince, Haiti—Last month, WholeFoods covered efforts by industry companies to help those affected by the earthquake that hit Port-au-Prince, Haiti in January. Since the time of that publication, several other companies have offered their support:
Arlington Heights, IL—Founded by John and Susan Carlson in 1965, Carlson Laboratories, still a family-owned and -operated business, is proud to celebrate its 45th anniversary. The Carlson family was aware of the powerful antioxidant benefits associated with vitamin E, especially in the d-alpha-tocopheryl succinate form.
Washington, D.C.—Last month, WholeFoods reported on proposed legislation sponsored by Arizona Senator John McCain (R-AZ) that would redefine dietary supplements and place new burdens on the dietary supplement industry. In the weeks that followed, several industry companies and associations responded to the Dietary Supplement Safety Act (DSSA, S3.002) in full force.
Rockville, MD—The U.S. Food and Drug Administration (FDA) would like to see some extra funding in FY 2011: $146 million from the government and $601 million in industry user fees. This 23% total increase (from $3.28 billion to $4.03 billion in all) will be invested in much-needed initiatives to protect public health. Specifically, FDA hopes to use this money to benefit food safety practice, medical product safety and regulatory science.
Alexandria, VA—Consumers who are concerned about the safety of dietary supplements should pay attention to a new statistic offered by the American Association of Poison Control Centers. According to the U.S. National Poison Data System, dietary supplements caused no deaths in 2008.
Washington, D.C.—WholeFoods continues its coverage of the lawsuit brought against the U.S. Food and Drug Administration (FDA) regarding qualified health claims for selenium and health claim censorship with an update.
New York, NY—WholeFoods reported last month on the U.S. Food and Drug Administration’s (FDA) publication of draft guidelines concerning the distinction between beverages and liquid dietary supplements. Since then, as part of the commentary phase of the FDA guideline process, Ullman, Shapiro and Ullman, LLP have submitted a thorough response statement in opposition to the proposed FDA guidelines.